H. Kan

751 total citations
33 papers, 582 citations indexed

About

H. Kan is a scholar working on Rheumatology, Economics and Econometrics and Molecular Biology. According to data from OpenAlex, H. Kan has authored 33 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 7 papers in Economics and Econometrics and 6 papers in Molecular Biology. Recurrent topics in H. Kan's work include Systemic Lupus Erythematosus Research (11 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Healthcare Policy and Management (4 papers). H. Kan is often cited by papers focused on Systemic Lupus Erythematosus Research (11 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Healthcare Policy and Management (4 papers). H. Kan collaborates with scholars based in United States, United Kingdom and Japan. H. Kan's co-authors include Yongsen Ruan, C. Molta, Christopher Collins, Kafait U. Malik, Maria Dall’Era, Cynthia Macahilig, David J. Chang, Rachel Turner, John Adams and Matthias Schonlau and has published in prestigious journals such as Diabetes, Journal of Pharmacology and Experimental Therapeutics and Annals of the Rheumatic Diseases.

In The Last Decade

H. Kan

31 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Kan United States 13 153 114 94 90 85 33 582
Alex Mercer United States 12 73 0.5× 159 1.4× 120 1.3× 50 0.6× 195 2.3× 32 1.1k
Erika Brown United States 12 114 0.7× 136 1.2× 25 0.3× 14 0.2× 38 0.4× 40 706
Julie Lemieux Canada 20 34 0.2× 343 3.0× 27 0.3× 73 0.8× 72 0.8× 83 1.6k
Nick Wilkinson United Kingdom 10 171 1.1× 27 0.2× 105 1.1× 28 0.3× 17 0.2× 26 597
Patrik Vankrunkelsven Belgium 13 140 0.9× 42 0.4× 14 0.1× 42 0.5× 28 0.3× 43 990
Kathleen Herkommer Germany 21 149 1.0× 185 1.6× 36 0.4× 71 0.8× 56 0.7× 96 1.2k
Peng Sun China 23 38 0.2× 497 4.4× 30 0.3× 62 0.7× 46 0.5× 80 1.8k
Claude Schmitt United Kingdom 13 127 0.8× 206 1.8× 84 0.9× 22 0.2× 7 0.1× 31 772

Countries citing papers authored by H. Kan

Since Specialization
Citations

This map shows the geographic impact of H. Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Kan more than expected).

Fields of papers citing papers by H. Kan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Kan. The network helps show where H. Kan may publish in the future.

Co-authorship network of co-authors of H. Kan

This figure shows the co-authorship network connecting the top 25 collaborators of H. Kan. A scholar is included among the top collaborators of H. Kan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Kan. H. Kan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ard, Jamy D., Lee M. Kaplan, Rekha B. Kumar, et al.. (2025). Perspectives on Obesity Management and the Use of Anti-Obesity Medicine from US Employees and Employers: Results from the OBSERVE Study. Population Health Management. 28(3). 150–160.
2.
Hankosky, Emily R., Hui Wang, H. Kan, et al.. (2023). SAT658 Tirzepatide Reduces The Predicted Risk Of Developing Atherosclerotic Cardiovascular Disease: A Post-hoc Analysis Of The Surmount-1 Trial. Journal of the Endocrine Society. 7(Supplement_1). 1 indexed citations
3.
Poon, Jiat Ling, et al.. (2022). A qualitative study to examine meaningful change in physical function associated with weight-loss. Quality of Life Research. 32(5). 1329–1340. 3 indexed citations
4.
Fransen, Bas L., et al.. (2018). Cross-cultural adaptation and validation of the Dutch version of the High Activity Arthroplasty Score. Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam). 25(3). 68–74. 2 indexed citations
5.
Kan, H., Daniel C. Pan, & Vincent Castranova. (2018). Engineered nanoparticle exposure and cardiovascular effects: the role of a neuronal-regulated pathway. Inhalation Toxicology. 30(9-10). 335–342. 25 indexed citations
6.
Hammond, Edward R., H. Kan, Jonothan C. Tierce, et al.. (2017). SAT0227 Health care utilization and costs of systemic lupus erythematosus (SLE) in the united states: systematic review. Annals of the Rheumatic Diseases. 76. 859–860. 4 indexed citations
7.
Collins, Christopher, Maria Dall’Era, H. Kan, et al.. (2016). Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USA. Lupus Science & Medicine. 3(1). e000118–e000118. 91 indexed citations
8.
Zheng, Weihui, Walter McKinney, Michael L. Kashon, et al.. (2015). The influence of inhaled multi-walled carbon nanotubes on the autonomic nervous system. Particle and Fibre Toxicology. 13(1). 8–8. 18 indexed citations
9.
Collins, Christopher, Maria Dall’Era, Cynthia Macahilig, et al.. (2014). FRI0374 Outcomes in Systemic Lupus Erythematosus Patients with High Disease Activity Treated with Belimumab: 18 Month Results from the US Observe Study. Annals of the Rheumatic Diseases. 73. 522–522. 1 indexed citations
10.
11.
12.
Lim, S. Sam, G. Dennis, H. Kan, et al.. (2012). AB1331 The impact of systemic lupus erythematosus on employment loss from a population-based cohort. Annals of the Rheumatic Diseases. 71. 714–714. 1 indexed citations
13.
Glovaci, Diana, Shaista Malik, Stanley S. Franklin, et al.. (2012). Comparison of demographic factors and cardiovascular risk factor control among U.S. adults with type 2 diabetes by insulin treatment classification. Journal of Diabetes and its Complications. 26(3). 169–174. 50 indexed citations
14.
King, Derek, et al.. (2010). Cost-effectiveness analysis of aripiprazole vs standard-of-care in the management of community-treated patients with schizophrenia: STAR study. Current Medical Research and Opinion. 27(2). 365–374. 10 indexed citations
15.
McEwan, P, Marc Evans, H. Kan, & Klas Bergenheim. (2009). Understanding the inter‐relationship between improved glycaemic control, hypoglycaemia and weight change within a long‐term economic model. Diabetes Obesity and Metabolism. 12(5). 431–436. 32 indexed citations
16.
Buntin, Melinda, José J. Escarce, Dana P. Goldman, et al.. (2004). Increased Medicare Expenditures for Physicians' Services: What are the Causes?. INQUIRY The Journal of Health Care Organization Provision and Financing. 41(1). 83–94. 10 indexed citations
17.
18.
Haque, Rizwanul, H. Kan, & Mitchell S. Finkel. (1998). Effects of cytokines and nitric oxide on myocardial E-C coupling. Basic Research in Cardiology. 93(7). s086–s094. 18 indexed citations
19.
Kan, H., Yongsen Ruan, & Kafait U. Malik. (1997). Signal Transduction Mechanism(s) Involved in Prostacyclin Production Elicited by Acetylcholine in Coronary Endothelial Cells of Rabbit Heart. Journal of Pharmacology and Experimental Therapeutics. 282(1). 113–122. 12 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alex Mercer Breakdown of academic impact, for papers by Erika Brown Breakdown of academic impact, for papers by Julie Lemieux Breakdown of academic impact, for papers by Nick Wilkinson Breakdown of academic impact, for papers by Patrik Vankrunkelsven Breakdown of academic impact, for papers by Kathleen Herkommer Breakdown of academic impact, for papers by Peng Sun Breakdown of academic impact, for papers by Claude Schmitt
Rankless by CCL
2026